Read full interview here (german version only).
Targeted Metabolomics
We develop improved diagnostic testing for conditions related to metabolic dysfunction, including chronic kidney, liver and cardiac diseases.
NMR Metabolomics
From a single serum sample, we quantify multiple biomarkers — known and newly discovered. Precision Diagnostics.
AXINON® System
Using FDA-cleared technology, this is our core platform. It incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy. It's the first modular software-based system for clinical diagnostics.